Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02924636
Other study ID # 2015_03
Secondary ID 2015-A00937-42
Status Recruiting
Phase N/A
First received
Last updated
Start date November 13, 2017
Est. completion date November 2023

Study information

Verified date January 2023
Source University Hospital, Lille
Contact Philippe Deruelle, MD,PhD
Phone +33 320446307
Email philippe.deruelle@chru-lille.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the efficacy of an electronic-based intervention to help pregnant overweight and obese women gain an appropriate amount of weight and improve their delivery i.e. to reduce the rate of labour procedures and interventions. We chose a composite outcome including instrumental delivery and Caesarean section, as clinically relevant outcomes because the mode of delivery is one of the major goals of the obstetrical management and is is strongly associated with body mass index and gestational weight gain.


Description:

Our study is an open, multicenter, randomized, parallel-group, controlled trial. This study will include obese pregnant women recruited in 11 French university hospitals. Patients will be randomized into two-parallel groups. One group underwent the electronic-personalized program (the interventional group) and the other underwent standard care (the control group). Due to the intervention by itself, a blind study would not be achievable. Intervention group (the electronic-personalized program) The intervention will be presented as a comprehensive dietary and lifestyle intervention called "e-PPOP-ID" (electronic Personalized Programmed for Obesity in Pregnancy to Improve Delivery), including a combination of dietary, exercise, and behavioral strategies delivered on a web site. The intervention will start at the latest by 20 weeks of pregnancy throughout the pregnancy and 8 weeks post-partum. Pregnant women of the intervention group will be given an access to a personalized patient centric e-health platform. The platform we be specifically designed for this program. Various modules of this platform will be activated: - An e-learning program: An e-Learning module will propose personalized content to each patient. Before the program, patients have to fill in questionnaires about food consumption (FFQ), Eating behavior (TFEQ) and physical activity (IPAQ). The answers of these questionnaires will be taken into account to define the e-learning lessons that patients must follow.Multi educational supports such as videos, fact sheets, quiz will be integrated into this program. Patient will be motivated to validate their program thanks to a reward system (access to new content by earning stars) and their knowledge can be estimated thanks to a quiz system. Dieticians and adapted physical education teachers will develop the content.These lessons will include nutritional needs, motivational and behavioral advices, recipes, and movies of exercises easily achievable. The objective e-learning program is to limit weight gain by encouraging to healthy balance of carbohydrates, fat, protein, reducing high-energy foods intake (refined carbohydrates and saturated fats), increasing intake of fruits and vegetables and also by encouraging to physical activity. A second evaluation at around the 30th gestational weeks will allow adapting the lessons of the e-learning program, according to the progress of patients. A Social network: The platform will propose various social networking tools that can link the patient together or link the patient with the care team. Using a pseudo, patient will be able to connect together and interact with various tools such as a secured instant message system, a secured videoconference and a forum. Motivation concepts Pregnant women will receive emails, which will encourage them to log in website and follow an e-learning lessons.A newsletter will be sent every month and will link to the new contents of the web site.Adhesion of program will be measured monthly by self-questionnaire of satisfaction and by measuring the time spent on the website including the forum. Control group (Standard care): The control group will receive standard care with oral information about the goal of nutritional needs during pregnancy and gestational weight gain guidelines according to BMI.


Recruitment information / eligibility

Status Recruiting
Enrollment 860
Est. completion date November 2023
Est. primary completion date November 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Obese pregnant women (30 = BMI < 40 kg/m2) - Singleton pregnancy between 12+0 to 19+6 weeks of pregnancy - Having an email address and an Internet access Exclusion Criteria: - BMI < 30 kg/m2 or BMI > 40 kg/m2 - History of more than 2 miscarriages - Severe heart disease (arrhythmias, history of myocardial infarction) - Multiple pregnancy - Unstable thyroid disease - Uncontrolled hypertension - Pre-gestational diabetes - Bariatric surgery - Any medical condition that may interfere with physical activity during pregnancy - No access to Internet - Minor - Absence of health insurance - Guardianship - Refusal to participate in research

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
ePPOP-ID program
This is a personalized and online program. The website will provide secure communication with dietician and lifestyle coaches.

Locations

Country Name City State
France CHU Lille Lille

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Lille Ministry of Health, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary rate of obstetrical interventions Caesarean section and instrumental delivery (forceps and vacuum extractor) at birth
Secondary Total gestational weight gain at birth
Secondary Gestational hypertension blood pressure > 140 and/or 90 mmHg after 20 weeks at birth
Secondary Preeclampsia gestational hypertension and proteinuria = 0.30 g/24 h at birth
Secondary Gestational diabetes mellitus Diagnosed by a 75g-oral glucose tolerance test (OGTT) between 24 and 28 according to French guidelines and International Association diabetic and Pregnancy Study Group at birth
Secondary Premature birth at birth
Secondary gestational age at birth
Secondary Birth weight at birth
Secondary Apgar score at birth
Secondary Arterial umbilical cord pH at birth
Secondary Neonatal traumatism composite outcome (shoulder dystocia + fracture + brachial plexus injury) at birth
Secondary Hyperbilirubinemia 1st week after birth
Secondary Neonatal respiratory distress syndrome 1st week after birth
Secondary Transfer in neonatal intensive care unit 1st week after birth
Secondary Maternal fever 1st week after delivery
Secondary Thromboembolic event 1st week after delivery
Secondary Hemorrhage 1st week after delivery
Secondary Breastfeeding duration 8 weeks +/- 2 weeks after delivery
Secondary Maternal weight 8 weeks +/- 2 weeks after delivery
Secondary child weight 8 weeks +/- 2 weeks after delivery
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2